Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1875 of 2529 entries
View as:

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01368536 Org: User:
Start: 05/31/11 End: 02/29/12 Due: 02/28/13

BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT02160041 Org: User:
Start: 07/24/14 End: 04/30/18 Due: 04/30/19

Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00171834 Org: User:
Start: 08/31/03 End: 09/30/08 Due: 09/30/09

Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01278342 Org: User:
Start: 09/30/06 End: 11/30/09 Due: 11/30/10

Russian Registry of Patients With nAMD

Phase: N/A Priority: Normal
NCT ID: NCT04935411 Org: User:
Start: 12/20/20 End: 12/05/22 Due: 12/05/23

Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

Phase: N/A Priority: Normal
NCT ID: NCT04564053 Org: User:
Start: 09/23/20 End: 12/10/20 Due: 12/10/21

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00870584 Org: User:
Start: 03/31/09 End: 03/31/10 Due: 03/31/11

Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.

Phase: N/A Priority: Normal
NCT ID: NCT02554890 Org: User:
Start: 04/29/16 End: 07/24/18 Due: 07/24/19

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

Phase: N/A Priority: Normal
NCT ID: NCT03203850 Org: User:
Start: 01/11/18 End: 04/17/23 Due: 04/17/24

Home Reported Outcomes in PNH

Phase: N/A Priority: Normal
NCT ID: NCT06411626 Org: User:
Start: 06/11/24 End: 05/15/25 Due: 05/15/26

A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00738257 Org: User:
Start: 06/30/00 End: - Due: -

Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib

Phase: N/A Priority: Normal
NCT ID: NCT02115386 Org: User:
Start: 12/17/15 End: 10/31/16 Due: 10/31/17

A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01546428 Org: User:
Start: 02/29/12 End: 01/31/16 Due: 01/31/17

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Phase: N/A Priority: Normal
NCT ID: NCT04807400 Org: User:
Start: 07/07/21 End: 01/13/23 Due: 01/13/24

A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04239027 Org: User:
Start: 01/26/21 End: 02/02/23 Due: 02/02/24

Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01495247 Org: User:
Start: 01/30/12 End: 05/19/14 Due: 05/19/15

Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Phase: N/A Priority: Normal
NCT ID: NCT03439839 Org: User:
Start: 04/09/18 End: 02/28/22 Due: 02/28/23

Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066

Phase: N/A Priority: Normal
NCT ID: NCT03198767 Org: User:
Start: 06/21/17 End: 09/04/17 Due: 09/04/18

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

Phase: N/A Priority: Normal
NCT ID: NCT00886769 Org: User:
Start: 07/31/09 End: 01/31/11 Due: 01/31/12

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01569815 Org: User:
Start: 02/28/09 End: 08/31/14 Due: 08/31/15

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06780670 Org: User:
Start: 02/27/25 End: 05/31/33 Due: 05/31/34

Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)

Phase: N/A Priority: Normal
NCT ID: NCT02720107 Org: User:
Start: 05/12/16 End: 11/14/16 Due: 11/14/17

An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU

Phase: N/A Priority: Normal
NCT ID: NCT04109313 Org: User:
Start: 10/24/19 End: 09/09/22 Due: 09/09/23

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00857259 Org: User:
Start: 02/28/09 End: - Due: -

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings

Phase: N/A Priority: Normal
NCT ID: NCT05918809 Org: User:
Start: 07/25/21 End: 06/17/22 Due: 06/17/23